학술논문
39 - Updated Results from Phase 2 Study of Guadecitabine for Patients with Untreated INT-2/High Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Document Type
Abstract
Author
Source
In Leukemia Research April 2017 55 Supplement 1:S25-S26
Subject
Language
ISSN
0145-2126